Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer. / Christensen, Ida Bager; Abrahamsen, Marie Louise; Ribas, Lucas; Buch-Larsen, Kristian; Marina, Djordje; Andersson, Michael; Larsen, Steen; Schwarz, Peter; Dela, Flemming; Gillberg, Linn.

In: Cancer Medicine, Vol. 12, No. 16, 2023, p. 16985-16996.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, IB, Abrahamsen, ML, Ribas, L, Buch-Larsen, K, Marina, D, Andersson, M, Larsen, S, Schwarz, P, Dela, F & Gillberg, L 2023, 'Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer', Cancer Medicine, vol. 12, no. 16, pp. 16985-16996. https://doi.org/10.1002/cam4.6333

APA

Christensen, I. B., Abrahamsen, M. L., Ribas, L., Buch-Larsen, K., Marina, D., Andersson, M., Larsen, S., Schwarz, P., Dela, F., & Gillberg, L. (2023). Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer. Cancer Medicine, 12(16), 16985-16996. https://doi.org/10.1002/cam4.6333

Vancouver

Christensen IB, Abrahamsen ML, Ribas L, Buch-Larsen K, Marina D, Andersson M et al. Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer. Cancer Medicine. 2023;12(16):16985-16996. https://doi.org/10.1002/cam4.6333

Author

Christensen, Ida Bager ; Abrahamsen, Marie Louise ; Ribas, Lucas ; Buch-Larsen, Kristian ; Marina, Djordje ; Andersson, Michael ; Larsen, Steen ; Schwarz, Peter ; Dela, Flemming ; Gillberg, Linn. / Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer. In: Cancer Medicine. 2023 ; Vol. 12, No. 16. pp. 16985-16996.

Bibtex

@article{ad5016bf28ef4f27b772f36051b83960,
title = "Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer",
abstract = "Background: Adjuvant chemo- and radiotherapy cause cellular damage to tumorous and healthy dividing cells. Chemotherapy has been shown to cause mitochondrial respiratory dysfunction in non-tumorous tissues, but the effects on human peripheral blood mononuclear cells (PBMCs) remain unknown. Aim: We aimed to investigate mitochondrial respiration of PBMCs before and after adjuvant chemo- and radiotherapy in postmenopausal patients with early breast cancer (EBC) and relate these to metabolic parameters of the patients. Methods: Twenty-three postmenopausal women diagnosed with EBC were examined before and shortly after chemotherapy with (n = 18) or without (n = 5) radiotherapy. Respiration (O2 flux per million PBMCs) was assessed by high-resolution respirometry of intact and permeabilized PBMCs. Clinical metabolic characteristics and mitochondrial DNA (mtDNA) content of PBMCs (mtDN relative to nuclear DNA) were furthermore assessed. Results: Respiration of intact and permeabilized PBMCs from EBC patients significantly increased with adjuvant chemo- and radiotherapy (p = 6 × 10−5 and p = 1 × 10−7, respectively). The oxygen flux attributed to specific mitochondrial complexes and respiratory states increased by 17–43% compared to before therapy initiation. Similarly, PBMC mtDNA content increased by 40% (p = 0.002). Leukocytes (p = 0.0001), hemoglobin (p = 0.0003), and HDL cholesterol (p = 0.003) concentrations decreased whereas triglyceride (p = 0.01) and LDL (p = 0.02) concentrations increased after treatment suggesting a worsened metabolic state. None of the metabolic parameters or the mtDNA content of PBMCs correlated significantly with PBMC respiration. Conclusion: This study shows that mitochondrial respiration and mtDNA content in circulating PBMCs increase after adjuvant chemo- and radiotherapy in postmenopausal patients with EBC. Besides the increased mtDNA content, a shift in PBMC subpopulation proportions towards cells relying on oxidative phosphorylation, who may be less sensitive to chemotherapy, might influence the increased mitochondrial respiration observed iafter chemotherapy.",
keywords = "breast cancer, chemotherapy, energy metabolism, high-resolution respirometry, mitochondria, peripheral blood mononuclear cells",
author = "Christensen, {Ida Bager} and Abrahamsen, {Marie Louise} and Lucas Ribas and Kristian Buch-Larsen and Djordje Marina and Michael Andersson and Steen Larsen and Peter Schwarz and Flemming Dela and Linn Gillberg",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.",
year = "2023",
doi = "10.1002/cam4.6333",
language = "English",
volume = "12",
pages = "16985--16996",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "JohnWiley & Sons Ltd",
number = "16",

}

RIS

TY - JOUR

T1 - Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer

AU - Christensen, Ida Bager

AU - Abrahamsen, Marie Louise

AU - Ribas, Lucas

AU - Buch-Larsen, Kristian

AU - Marina, Djordje

AU - Andersson, Michael

AU - Larsen, Steen

AU - Schwarz, Peter

AU - Dela, Flemming

AU - Gillberg, Linn

N1 - Publisher Copyright: © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

PY - 2023

Y1 - 2023

N2 - Background: Adjuvant chemo- and radiotherapy cause cellular damage to tumorous and healthy dividing cells. Chemotherapy has been shown to cause mitochondrial respiratory dysfunction in non-tumorous tissues, but the effects on human peripheral blood mononuclear cells (PBMCs) remain unknown. Aim: We aimed to investigate mitochondrial respiration of PBMCs before and after adjuvant chemo- and radiotherapy in postmenopausal patients with early breast cancer (EBC) and relate these to metabolic parameters of the patients. Methods: Twenty-three postmenopausal women diagnosed with EBC were examined before and shortly after chemotherapy with (n = 18) or without (n = 5) radiotherapy. Respiration (O2 flux per million PBMCs) was assessed by high-resolution respirometry of intact and permeabilized PBMCs. Clinical metabolic characteristics and mitochondrial DNA (mtDNA) content of PBMCs (mtDN relative to nuclear DNA) were furthermore assessed. Results: Respiration of intact and permeabilized PBMCs from EBC patients significantly increased with adjuvant chemo- and radiotherapy (p = 6 × 10−5 and p = 1 × 10−7, respectively). The oxygen flux attributed to specific mitochondrial complexes and respiratory states increased by 17–43% compared to before therapy initiation. Similarly, PBMC mtDNA content increased by 40% (p = 0.002). Leukocytes (p = 0.0001), hemoglobin (p = 0.0003), and HDL cholesterol (p = 0.003) concentrations decreased whereas triglyceride (p = 0.01) and LDL (p = 0.02) concentrations increased after treatment suggesting a worsened metabolic state. None of the metabolic parameters or the mtDNA content of PBMCs correlated significantly with PBMC respiration. Conclusion: This study shows that mitochondrial respiration and mtDNA content in circulating PBMCs increase after adjuvant chemo- and radiotherapy in postmenopausal patients with EBC. Besides the increased mtDNA content, a shift in PBMC subpopulation proportions towards cells relying on oxidative phosphorylation, who may be less sensitive to chemotherapy, might influence the increased mitochondrial respiration observed iafter chemotherapy.

AB - Background: Adjuvant chemo- and radiotherapy cause cellular damage to tumorous and healthy dividing cells. Chemotherapy has been shown to cause mitochondrial respiratory dysfunction in non-tumorous tissues, but the effects on human peripheral blood mononuclear cells (PBMCs) remain unknown. Aim: We aimed to investigate mitochondrial respiration of PBMCs before and after adjuvant chemo- and radiotherapy in postmenopausal patients with early breast cancer (EBC) and relate these to metabolic parameters of the patients. Methods: Twenty-three postmenopausal women diagnosed with EBC were examined before and shortly after chemotherapy with (n = 18) or without (n = 5) radiotherapy. Respiration (O2 flux per million PBMCs) was assessed by high-resolution respirometry of intact and permeabilized PBMCs. Clinical metabolic characteristics and mitochondrial DNA (mtDNA) content of PBMCs (mtDN relative to nuclear DNA) were furthermore assessed. Results: Respiration of intact and permeabilized PBMCs from EBC patients significantly increased with adjuvant chemo- and radiotherapy (p = 6 × 10−5 and p = 1 × 10−7, respectively). The oxygen flux attributed to specific mitochondrial complexes and respiratory states increased by 17–43% compared to before therapy initiation. Similarly, PBMC mtDNA content increased by 40% (p = 0.002). Leukocytes (p = 0.0001), hemoglobin (p = 0.0003), and HDL cholesterol (p = 0.003) concentrations decreased whereas triglyceride (p = 0.01) and LDL (p = 0.02) concentrations increased after treatment suggesting a worsened metabolic state. None of the metabolic parameters or the mtDNA content of PBMCs correlated significantly with PBMC respiration. Conclusion: This study shows that mitochondrial respiration and mtDNA content in circulating PBMCs increase after adjuvant chemo- and radiotherapy in postmenopausal patients with EBC. Besides the increased mtDNA content, a shift in PBMC subpopulation proportions towards cells relying on oxidative phosphorylation, who may be less sensitive to chemotherapy, might influence the increased mitochondrial respiration observed iafter chemotherapy.

KW - breast cancer

KW - chemotherapy

KW - energy metabolism

KW - high-resolution respirometry

KW - mitochondria

KW - peripheral blood mononuclear cells

U2 - 10.1002/cam4.6333

DO - 10.1002/cam4.6333

M3 - Journal article

C2 - 37439084

AN - SCOPUS:85165196801

VL - 12

SP - 16985

EP - 16996

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 16

ER -

ID: 362064604